These TCR chains, together with the engineered CD3z chain, were transduced into CD8+ T cells, where they induced CD8+ T cell cytotoxic activity and IFN-g secretion against peptide-pulsed autologous cells and HLA-A*02:01-positive and CT37-expressing lung cancer cell lines. The gene discussed is CD8A; the disease is lung cancer.